ALDEYRA THERAPEUTICS, INC. Public Float
ALDEYRA THERAPEUTICS, INC. (ALDX) had Public Float of $231.90 million as of 2025-06-30, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-27
- 2025-06-30: Entity Public Float $231.90M.
- 2024-06-30: Entity Public Float $191.74M.
- 2023-06-30: Entity Public Float $483.31M.
- 2022-06-30: Entity Public Float $228.38M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $231.90M 10-K · filed 2026-02-27 |
| 2024-06-30 | $191.74M 10-K/A · filed 2025-03-28 |
| 2023-06-30 | $483.31M 10-K · filed 2024-03-07 |
| 2022-06-30 | $228.38M 10-K/A · filed 2023-04-28 |
| 2021-06-30 | $648.69M 10-K · filed 2022-03-17 |
| 2020-06-28 | $127.66M 10-K · filed 2021-03-11 |
| 2019-06-28 | $152.79M 10-K · filed 2020-03-12 |
| 2018-06-29 | $148.31M 10-K · filed 2019-03-08 |
| 2017-06-30 | $60.47M 10-K · filed 2018-03-29 |
| 2016-06-30 | $59.22M 10-K · filed 2017-03-30 |
| 2015-06-30 | $59.34M 10-K · filed 2016-03-30 |
| 2014-06-30 | $11.94M 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |